Noteworthy - Pharmaceutical Executive



Reimbursement Limits Threaten Drug Access

May 22, 2014

Despite provisions in the Affordable Care Act that require qualified health plans to cover 'basic' benefits, access to prescription drugs may be limited by high out-of-pocket costs and tight pharmacy management strategies.

Rebuilding European Pharma's Competitive Agenda

May 19, 2014

Because of the tougher conditions they face and shifts in ownership and corporate strategy, EFPIA and EGA have started to work together much more closely.

Gravity Shift: What MNCs Can Learn from Generics

May 15, 2014

MNCs can learn a lot from generic companies in their strategic approaches to emerging markets.

Oncology: Still an Attractive Market?

May 13, 2014

In light of the risks and challenges inherent in the development of oncologics, some pharmacos are questioning whether it remains an attractive therapeutic area in which to invest its resources.

Brands of Yesteryear: Where Are They Now?

May 6, 2014

We check back with previous Pharm Exec Brand of the Year winners to see how things are going.

Africa: The Lost Continent No More

May 6, 2014

Driven by a rising GDP and calmer political and financial waters over the past decade, Africa's nascent healthcare sector is poised for a fresh surge in growth.

2014 Brand of the Year

May 1, 2014

Pharm Exec's Brand of the Year recipients for 2014 are multiple sclerosis treatment Copaxone and KORLYM for diseases driven by excess production of the metabolic hormone, cortisol. We profile the journey of both drugs.

What's Real in Deals

May 1, 2014

Recent deal making signals that the rehabilitation of big Pharma has entered a new phase aligned around a new strategic thesis, writes Pharm Exec Editor-in-Chief William Looney.

Diabetes Patients in China: Is Pharma Listening?

April 30, 2014

In China, diabetes patients are hungry for information about their condition, and are taking to social media to discuss it. But, asks Simon Li, is pharma paying attention?


Click here